Diagnostic Ultrasound launches Japanese unit

Article

Diagnostic Ultrasound of Redmond, WA, has established a subsidiary in Japan. Touchmetrics opened Jan. 1, and will support Diagnostic Ultrasound’s 3-D ultrasound products. The new company replaces Sumitomo, Diagnostic Ultrasound’s former

Diagnostic Ultrasound of Redmond, WA, has established a subsidiary in Japan. Touchmetrics opened Jan. 1, and will support Diagnostic Ultrasound’s 3-D ultrasound products. The new company replaces Sumitomo, Diagnostic Ultrasound’s former representative in Japan, although Sumitomo will continue as a nonexclusive distributor of Diagnostic Ultrasound’s products. Touchmetrics’ president is Seijiro Shirahama, formerly general manager of Bristol Meyers Squibb’s Convatech division.

Establishing Touchmetrics is part of Diagnostic Ultrasound’s effort to strengthen its global position: The company has a European subsidiary, DxU Europe, and distributor agreements in 50 countries around the world. Diagnostic Ultrasound reported annual sales of $17 million in 1999, and has 130 employees.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.